PHARMA PROJECT ENGINGEERING LTDActive

Company number SC602069Private limited companyIncorporated 2018
⚠ Confirmation statement overdue. It was due on 22 Jul 2026.

Key figures

£26,234-29.8%
Net assets 2024/25
-10.8%
Average annual change 2019/20–2024/25
020 k40 k60 k80 k2019/202020/212021/222022/232023/242024/25

Like most small UK companies, PHARMA PROJECT ENGINGEERING LTD does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.

Ratios

2024/25
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
050 k100 k2019/202020/212021/222022/232023/242024/25
Filed accounts2019/20–2024/25
2020/212021/222022/232023/242024/25
Total assets86,33073,52359,31045,16331,128
Total liabilities13,40420,83121,9067,7944,894
Net assets / total equity72,92652,69237,40437,36926,234
Average number of employees12221

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Summary: PHARMA PROJECT ENGINGEERING LTD

Company

PHARMA PROJECT ENGINGEERING LTD is a private limited company registered with Companies House under company number SC602069. It was incorporated on 9 Jul 2018. Its status is active. The registered office is in Dundee (DD1). Its nature of business (SIC 2007) is management consultancy activities other than financial management (70229), other engineering activities (71129).

Accounts

The latest accounts in the database are for 2024/25 (period ending 31 Jul 2025); the company files micro-entity accounts. Net assets were £26,234, down 29.8% on the previous year. Total assets were £31,128 and total liabilities £4,894. The company had an average of 1 employee. Figures are available for 6 financial years (2019/20–2024/25).

Control and charges

2 persons with significant control are registered.

Filing deadlines

The next accounts are due by 30 Apr 2027. The next confirmation statement is due by 22 Jul 2026.